Clinical trials recruiting for Vaso-Occlusive Pain Episode in Sickle Cell Disease
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Depot medroxyprogesterone acetate (DMPA) | 1 |
| Lidocain | 1 |
| Sub-dissociative Ketamine Infusion | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| California | 1 |
| Georgia | 1 |
| Maryland | 1 |
| Pennsylvania | 1 |
Top cities
Self-screener
Recruiting trials
- Clinical and Biomarker Effects of Depot Medroxyprogesterone Acetate in Females With Sickle Cell Disease
- Lidocaine for Opioid Sparing in Vaso-occlusive Crisis of Sickle Cell Disease
- Sub-dissociative Dose Ketamine in Treatment of Vaso-occlusive Pain Event in Children and Young Adults
- Virtual Reality Devices as an Adjunct to Usual Care for Patients With Sickle Cell Disease Experiencing Vaso-Occlusive Crises
Related conditions
Trials recruiting for Vaso-Occlusive Pain Episode in Sickle Cell Disease often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Vaso-Occlusive Pain Episode in Sickle Cell Disease trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.